Lee Hwangbo Selected Research

A-130A (A 130)

2/2022

Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lee Hwangbo Research Topics

Disease

3	Neoplasms (Cancer) 02/2022 - 01/2021
3	Breast Neoplasms (Breast Cancer) 02/2022 - 01/2020
1	Triple Negative Breast Neoplasms 02/2022
1	Stroke (Strokes) 12/2020
1	Thrombosis (Thrombus) 12/2020
1	Heart Arrest (Cardiac Arrest) 12/2020
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Brain Edema (Cerebral Edema) 12/2014
1	Hemorrhage 01/2014
1	Fat Embolism 01/2014
1	Coronary Stenosis (Coronary Artery Stenosis) 05/2013

Drug/Important Bio-Agent (IBA)

3	Estrogen ReceptorsIBA 01/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2020
2	EmulsionsIBA 12/2014 - 01/2014
2	TrioleinIBA 12/2014 - 01/2014
1	A-130A (A 130)IBA 02/2022
1	Biological ProductsIBA 02/2022
1	Phenobarbital (Luminal)FDA Link 02/2022
1	human ERBB2 proteinIBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 05/2013

Therapy/Procedure

1	Stents 12/2020